This study aimed to assess the clinical efficacy of Guimen Thirteen Needles combined with sertraline hydrochloride in treating mild-to-moderate poststroke depression (PSD).
Methods
A total of 96 mild-to-moderate PSD patients admitted from 2023 to 2024 were divided into observation group (A, combination therapy) and control group (B, sertraline monotherapy), with 48 cases each and matched baseline characteristics. Hamilton rating scale for depression (HAMD)-24; National Institutes of Health stroke scale (NIHSS); modified Barthel index (MBI); Brunnstrom stage scores; serum levels of mammalian target of rapamycin (mTOR), C-reactive protein (CRP), brain-derived neurotrophic factor (BDNF), 5-hydroxytryptamine (5-HT), tumor necrosis factor (TNF)-α, and dopamine (DA); clinical response rate; and adverse events were compared between the two groups.
Results
Repeated measures analysis of variance (ANOVA) showed significant time, group main effects, and time–group interaction for HAMD-24, MBI scores, and all laboratory indicators (all P < 0.05). NIHSS scores had a significant time effect and time–group interaction (P < 0.05), but no significant group effect (P > 0.05). There was no significant difference in Brunnstrom stages between Group A and Group B at 2 and 4 weeks of treatment (P > 0.05). Group A had a significantly higher clinical response rate (P < 0.05), while adverse event rates were comparable (P > 0.05).
Conclusion
The combination of Guimen Thirteen Needles acupuncture and sertraline hydrochloride in treating mild-to-moderate PSD can modulate laboratory indicators, improve neurological function and depressive symptoms, and enhance patient independence.
BakerC.WorrallL.RoseM.RyanB. (2021). Stroke health professionals’ management of depression after post-stroke aphasia: A qualitative study. Disability and Rehabilitation, 43(2), 217–228. https://doi.org/10.1080/09638288.2019.1621394
2.
BeeR.AhmadM.VermaS.Badruddeen, AkhtarJ.KhanM. I. (2024). An updated review on possible therapeutic role of vincamine via 5-HT receptors in the treatment of depression. Current Psychiatry Research and Reviews, 20(3), 199–208. https://doi.org/10.2174/2666082219666230726123452
3.
CastilloC. E. C.GaribayS. E. M.SegoviaR. D. C. M.GuzmánS. Z.CookH. J.ContrerasM. O.MorenoS. R. (2024). Population pharmacokinetics of Sertraline in psychiatric and substance use disorders. The Journal of Clinical Pharmacology, 64(10), 1267–1277. https://doi.org/10.1002/jcph.2457
4.
Chinese Society of Neurology & Cerebrovascular Disease Group of Chinese Society of Neurology (2019). Key diagnostic points for major cerebrovascular diseases in China (2019). Chinese Journal of Neurology, 52(9), 710–715. https://doi.org/10.3760/cma.j.issn.1006-7876.2019.09.003
5.
DuanJ. G.DingY.ShaoY. T. (2024). Research progress in the treatment of post-stroke depression with traditional Chinese medicine. Research and Inheritance of Traditional Chinese Medicine, 2(1), 33–37. https://doi.org/10.62022/RICM.issn3005-5482.2024.01.007
6.
EliasS.BenevidesM. L.MartinsA. L.Pereira MartinsA. L.MartinsG. L.Sperb Wanderley MarcosA. B.NunesJ. C. (2023). In-hospital symptoms of depression and anxiety are strong risk factors for post-stroke depression 90 days after ischemic stroke. The Neurohospitalist, 13(2), 121–129. https://doi.org/10.1177/19418744221132675
7.
GaoX. Y. (2006). Clinical Acupuncture and Moxibustion (pp. 103–105). People's Military Medical Press.
8.
HuH. M.SuL. (2024). A brief analysis of the thirteen ghost points acupuncture technique. Clinical Journal of Traditional Chinese Medicine, 36(3), 463–467.
9.
JasterA. M.ElderH.MarshS. A.de la Fuente RevengaM.NegusS. S.González-MaesoJ. (2022). Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents. Psychopharmacology, 239(6), 1665–1677. https://doi.org/10.1007/s00213-022-06092-x
10.
JiangG. Z.ZhouD. J.YanX. M.ZhengQ.TangZ. (2022). Association between C-reactive protein levels and development of post-stroke depression: A systematic review and meta-analysis. Scottish Medical Journal, 67(4), 135–143. https://doi.org/10.1177/00369330221117557
11.
LiK. D.MoD.YuQ.FengR.LiY. (2024). Effect of repetitive transcranial magnetic stimulation on post-stroke comorbid cognitive impairment and depression: A randomized controlled trial. Journal of Alzheimer’s Disease, 101(1), 337–352. https://doi.org/10.3233/JAD-240505
12.
MaX. F. (2012). Practical Internal Medicine of Traditional Chinese Medicine (p. 215). Shaanxi Science and Technology Press.
13.
MaieseK. (2023). Clinical depression, the mechanistic target of rapamycin (mTOR), and forkhead transcription factors (FoxOs). Current Neurovascular Research, 20(4), 429–433. https://doi.org/10.2174/1567202620999230928124725
14.
MasuccioF. G.GrangeE.Di GiovanniR.RollaM.SolaroC. M. (2024). Post-stroke depression in older adults: An overview. Drugs and Aging, 41(4), 303–318. https://doi.org/10.1007/s40266-024-01104-1
15.
MiyanishiH.NittaA. (2021). A role of BDNF in the depression pathogenesis and a potential target as antidepressant: The modulator of stress sensitivity “Shati/Nat8l-BDNF system” in the Dorsal Striatum. Pharmaceuticals, 14(9), 889. https://doi.org/10.3390/ph14090889
16.
MonfortA.CardosoE.EapC. B.AnsermotN.CrettolS.Fischer FumeauxC. J.GrazM. B.HarariM. M.WeisskopfE.GandiaP.AllegaertK.AnnaertP.NordengH.HascoëtJ.ClarisO.EpineyM.FerreiraE.LeclairG.CsajkaC.…GuidiM. (2024). A population pharmacokinetic model for Sertraline in women during the perinatal period—A contribution from the ConcePTION project. British Journal of Clinical Pharmacology, 90(11), 2849–2860. https://doi.org/10.1111/bcp.16177
17.
PangH. Q.GuoJ. X.ShangX. Y.WangJ.LiuH.TianJ.ZhangL.WangJ.-B.ShiW.YanB.-C.LiuL. (2024). Uncovering chemical interactions between Danshen and Danggui using liquid chromatography–mass spectrometry and network pharmacology-based research on stroke. World Journal of Traditional Chinese Medicine, 10(2), 230–243. https://doi.org/10.4103/wjtcm.wjtcm_45_23
18.
PetersH. T.WhiteS. E.PageS. J. (2015). The National Institutes of Health stroke scale lacks validity in chronic hemiparetic stroke. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association, 24(10), 2207–2212. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.05.011
19.
RibeiroN. F.MadrugaL. (2021). A sudden and severe depressive episode after a left cingulate gyrus stroke: A case report of post-stroke depression and review of literature. Journal of Neural Transmission, 128(5), 711–716. https://doi.org/10.1007/s00702-021-02334-y
20.
RossR. E.VanDerwerkerC. J.GeorgeM. S.GregoryC. M. (2023). Feasibility of performing a multi-arm clinical trial examining the novel combination of repetitive transcranial magnetic stimulation and aerobic exercise for post-stroke depression. Topics in Stroke Rehabilitation, 30(7), 649–662. https://doi.org/10.1080/10749357.2023.2165258
21.
SabassL.PadbergF.NormannC.EngelV.KonradC.HelmleK.JobstA.WorlitzA.BrakemeierE.-L. (2018). Cognitive behavioral analysis system of psychotherapy as group psychotherapy for chronically depressed inpatients: A naturalistic multicenter feasibility trial. European Archives of Psychiatry and Clinical Neuroscience, 268(8), 783–796. https://doi.org/10.1007/s00406-017-0843-5
22.
ShaL.XuT. T.GeX. J.ShiL.ZhangJ.GuoH. (2021). Predictors of death within 6 months of stroke onset: A model with Barthel index, platelet/lymphocyte ratio and serum albumin. Nursing Open, 8(3), 1380–1392. https://doi.org/10.1002/nop2.754
23.
SmithA. L. W.HarmerC. J.CowenP. J.MurphyS. E. (2023). The serotonin 1A (5-HT1A) receptor as a pharmacological target in depression. CNS Drugs, 37(7), 571–585. https://doi.org/10.1007/s40263-023-01014-7
24.
WangS. S.ZhouX. Y.ZhuC. Y. (2016). Chinese Expert consensus on clinical practice of post-stroke depression. Chinese Journal of Stroke, 11(8), 685–693.
25.
WangY. H. (2022). Effects of acupuncture combined with Brunnstrom staging on upper-limb motor function, cerebral arterial blood flow velocity, and brain function remodeling after stroke. Journal of Acupuncture and Tuina Science, 20(1), 49–57. https://doi.org/10.1007/s11726-022-1291-y
